Pasithea Therapeutics Corp.
NASDAQ: KTTA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tiago Reis Marques
- Employees
- 4
- Headquarters
- Miami Beach, United States
- IPO year
- 2021
- Market cap
- $4.1M
- Website
- https://www.pasithea.com
Loading KTTA…
Loading profile data…Frequently asked questions about KTTA
What does Pasithea Therapeutics Corp. (KTTA) do?
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to o...
Where does KTTA trade?
Pasithea Therapeutics Corp. (KTTA) trades on the NASDAQ Capital Market.
What sector is KTTA in?
Pasithea Therapeutics Corp. (KTTA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pasithea Therapeutics Corp.?
Tiago Reis Marques is the chief executive officer of Pasithea Therapeutics Corp. (KTTA).
Where is Pasithea Therapeutics Corp. headquartered?
Pasithea Therapeutics Corp. is headquartered in United States.
Does KTTA pay a dividend?
Pasithea Therapeutics Corp. (KTTA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KTTA go public?
Pasithea Therapeutics Corp. (KTTA) completed its initial public offering in 2021.